Beverly, MA, United States of America

Zhenyu Zhu

This inventor holds 36 USPTO granted patents and 8 published patent applications and 20 EPO patents, primarily in Restriction Endonucleases. Top assignees: New England Biolabs, Inc., Indian Institute of Science, Other. Active years: 2002-2026.

USPTO Granted Patents = 36 

% Patents Active = 91.7

 

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Restriction Endonucleases
Hydroxymethylcytosine
Cytosine Modifications
Nicking Endonuclease
Cloning Methods
DNA Cleaving
Polynucleotides
BsaI Methylase
Tth111II
BsmAi
KpnI Variant
36 patents (USPTO):Explore Patents

Title: The Innovative Journey of Zhenyu Zhu

Introduction: Zhenyu Zhu, a talented inventor based in Beverly, MA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Zhenyu Zhu's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring health metrics in real-time.

Career Highlights: With a background in computer science and engineering, Zhenyu Zhu has a successful track record of developing innovative solutions for complex technological challenges. He has received multiple awards for his contributions to the industry.

Collaborations: Zhenyu Zhu has collaborated with leading tech companies and research institutions to further advance his inventions. His collaborative spirit has led to the development of cutting-edge technologies that have positively impacted various sectors.

Conclusion: Zhenyu Zhu's passion for innovation and his dedication to pushing the boundaries of technology make him a standout inventor in the field. His inventive spirit continues to inspire others in the industry to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…